GlassScriptPhysician profile
Raymond Janowski
NPI 1477972131
$1,782.19
in general payments reported to CMS, 2019-2025
12 companies · $70.53 in 2025
The $70.53 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $273 · 2022: $166 · 2023: $945 · 2024: $327 · 2025: $70.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,343.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,342.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $803.64 | 2019-2025 | Exalt Model D, Spyglass |
| Pentax of America, INC. | $287.26 | 2023-2024 | Pentax Medical, Inspira, C2 Cryoballoon Focal Controller |
| Abbvie INC. | $199.60 | 2023-2025 | |
| Celgene Corporation | $136.12 | 2023 | Zeposia |
| Janssen Scientific Affairs, LLC | $107.61 | 2023 | Stelara |
| Janssen Biotech, INC. | $99.00 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $42.66 | 2019 | |
| W. L. Gore & Associates, INC. | $23.22 | 2023 | Gore Cardioform Septal Occluder |
| Eisai INC. | $22.88 | 2019 | |
| Organon LLC | $22.32 | 2023 | Hadlima |
| Pfizer INC. | $22.26 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.62 | 2023 | Gattex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Janowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.